menu
    • menu

    Find Magnesium Sulfate manufacturers, exporters & distributors on PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    16

    API Suppliers

    API Suppliers

    12

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    4

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    4

    NDC API

    NDC API

    0

    VMF

    NDC API

    5

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 34

    MARKET PLACE

    16

    API

    6

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    107

    FDF Dossiers

    FDF Dossiers

    66

    FDA Orange Book

    FDA (Orange Book)

    14

    Europe

    Europe

    8

    Canada

    Canada

    0

    Australia

    Australia

    5

    South Africa

    South Africa

    14

    Listed Dossiers

    Listed Dossiers

    2DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    1

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    4

    US Patents

    1

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    45

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    162,000

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    166 RELATED EXCIPIENT COMPANIES

    269EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 7487-88-9, Magnesium sulphate, Magnesium sulfate anhydrous, Mgso4, Sulfuric acid magnesium salt (1:1), Magnesium sulfate (1:1)
    Molecular Formula
    MgO4S
    Molecular Weight
    120.37  g/mol
    InChI Key
    CSNNHWWHGAXBCP-UHFFFAOYSA-L
    FDA UNII
    ML30MJ2U7I
    Magnesium Sulfate
    A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
    1 2D Structure

    Magnesium Sulfate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    magnesium;sulfate
    2.1.2 InChI
    InChI=1S/Mg.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2
    2.1.3 InChI Key
    CSNNHWWHGAXBCP-UHFFFAOYSA-L
    2.1.4 Canonical SMILES
    [O-]S(=O)(=O)[O-].[Mg+2]
    2.2 Other Identifiers
    2.2.1 UNII
    ML30MJ2U7I
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Heptahydrate Magnesium Sulfate

    2. Magnesium Sulfate, Heptahydrate

    3. Sulfate, Magnesium

    2.3.2 Depositor-Supplied Synonyms

    1. 7487-88-9

    2. Magnesium Sulphate

    3. Magnesium Sulfate Anhydrous

    4. Mgso4

    5. Sulfuric Acid Magnesium Salt (1:1)

    6. Magnesium Sulfate (1:1)

    7. Magnesiumsulfat

    8. Magnesiumsulfate

    9. Magnesium Sulfate, Anhydrous

    10. Sulfuric Acid Magnesium Salt

    11. Magnesium(ii) Sulfate

    12. Magnesium;sulfate

    13. Magnesium Sulphate Anhydrous

    14. Sulfato De Magnesio

    15. Chebi:32599

    16. Mfcd00011110

    17. Magnesium Sulfate,anhydrous

    18. Ml30mj2u7i

    19. Magnesium Sulphate, Anhydrous

    20. Magnesium Sulfate Anhydrous

    21. Sulfuric Acid, Mono-c10-16-alkyl Esters, Magnesium Salts

    22. Sal Angalis

    23. Sal De Sedlitz

    24. Tomix Ot

    25. 139939-75-6

    26. Ot-s (drying Agent)

    27. Ot-s

    28. 68081-97-0

    29. Sulfuric Acid Magnesiumsalt (1:1), Hydrate (8ci,9ci)

    30. Caswell No. 534

    31. Magnesii Sulfas

    32. Magnesii Sulfas; Magnesium Sulfate; Magnesium Sulphate; Mg-ok; Ot-s

    33. Anhydrous Magnesium Sulfate

    34. Sulfuric Acid Magnesium Salt (van)

    35. Arrosalt 2327

    36. Hsdb 664

    37. Einecs 231-298-2

    38. Unii-ml30mj2u7i

    39. Epa Pesticide Chemical Code 050503

    40. Magnesium Sulfate In Plastic Container

    41. Nsc 146179

    42. Magnesium Sulfate, Unspecified

    43. Sda 15-062-07

    44. Ccris 8411

    45. Sn 00

    46. Einecs 242-691-3

    47. Einecs 268-365-0

    48. Sulfuric Acid, C10-16 Alkyl Ester, Magnesium Salt

    49. Sulphate Of Magnesia

    50. (c10-c16) Alkylalcohol Sulfuric Acid, Magnesium Salt

    51. Magnesium Sulfate In Dextrose 5% In Plastic Container

    52. Ai3-02029

    53. Epitope Id:158536

    54. Ec 231-298-2

    55. C10-c16 Alkyl Alcohol Sulfuric Acid Magnesium Salt

    56. Magnesium Sulfate [mi]

    57. Chembl2021423

    58. Dtxsid6042105

    59. Magnesium Sulfate [hsdb]

    60. Magnesium Sulfate, Anhydrous Powder

    61. Magnesium Sulfate, Anhydrous Granular

    62. Akos015902894

    63. Db00653

    64. Magnesium Sulfate, 1m Aqueous Solution

    65. Magnesium Sulfate Anhydrous [ii]

    66. 18939-43-0

    67. Magnesium Sulfate,anhydrous [vandf]

    68. Ft-0628097

    69. M1890

    70. Magnesium Sulfate Anhydrous [orange Book]

    71. Magnesium Sulfate Heptahydrate Solution, 2.25%

    72. Magnesium Sulfate, 1m Aqueous Solution, Sterile

    73. Magnesium Sulfate Anhydrous [usp Monograph]

    74. Q288266

    75. Sr-01000944338

    76. J-014575

    77. J-519590

    78. Sr-01000944338-1

    79. Magnesium Sulfate, Anhydrous Powder Trace Metals Grade, 99.95%

    80. Magnesium Sulfate, Anhydrous Granular Trace Metals Grade, 99.95%

    81. Suprep Bowel Prep Kit Component Magnesium Sulfate Anhydrous

    82. Magnesium Sulfate Anhydrous Component Of Suprep Bowel Prep Kit

    2.4 Create Date
    2004-09-16
    3 Chemical and Physical Properties
    Molecular Weight 120.37 g/mol
    Molecular Formula MgO4S
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count0
    Exact Mass119.9367713 g/mol
    Monoisotopic Mass119.9367713 g/mol
    Topological Polar Surface Area88.6 Ų
    Heavy Atom Count6
    Formal Charge0
    Complexity62.2
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameMagnesium sulfate
    PubMed HealthMagnesium Sulfate
    Drug ClassesAnti-Inflammatory, Anticonvulsant, Laxative, Laxative, Hyperosmotic, Parenteral Mineral-Trace Mineral, Renal-Urologic Agent
    Drug LabelMagnesium Sulfate in Water for Injection is a sterile, nonpyrogenic solution of magnesium sulfate heptahydrate in water for injection. May contain sulfuric acid and/or sodium hydroxide for pH adjustment. The pH is 4.5 (3.5 to 6.5). It is available in...
    Active IngredientMagnesium sulfate
    Dosage FormInjectable
    RouteInjection
    Strength500mg/ml
    Market StatusPrescription
    CompanyHospira; Fresenius Kabi Usa

    2 of 4  
    Drug NameMagnesium sulfate in plastic container
    Active IngredientMagnesium sulfate
    Dosage FormInjectable
    RouteInjection
    Strength4gm/100ml (40mg/ml); 4gm/50ml (80mg/ml); 2gm/50ml (40mg/ml); 20gm/500ml (40mg/ml); 40gm/1000ml(40mg/ml)
    Market StatusPrescription
    CompanyHospira

    3 of 4  
    Drug NameMagnesium sulfate
    PubMed HealthMagnesium Sulfate
    Drug ClassesAnti-Inflammatory, Anticonvulsant, Laxative, Laxative, Hyperosmotic, Parenteral Mineral-Trace Mineral, Renal-Urologic Agent
    Drug LabelMagnesium Sulfate in Water for Injection is a sterile, nonpyrogenic solution of magnesium sulfate heptahydrate in water for injection. May contain sulfuric acid and/or sodium hydroxide for pH adjustment. The pH is 4.5 (3.5 to 6.5). It is available in...
    Active IngredientMagnesium sulfate
    Dosage FormInjectable
    RouteInjection
    Strength500mg/ml
    Market StatusPrescription
    CompanyHospira; Fresenius Kabi Usa

    4 of 4  
    Drug NameMagnesium sulfate in plastic container
    Active IngredientMagnesium sulfate
    Dosage FormInjectable
    RouteInjection
    Strength4gm/100ml (40mg/ml); 4gm/50ml (80mg/ml); 2gm/50ml (40mg/ml); 20gm/500ml (40mg/ml); 40gm/1000ml(40mg/ml)
    Market StatusPrescription
    CompanyHospira

    4.2 Therapeutic Uses

    Analgesics; Anesthetics; Anti-Arrhythmia Agents; Anticonvulsants; Calcium Channel Blockers; Cathartics; Tocolytic Agents

    National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)

    AN EFFECTIVE & WIDELY EMPLOYED SALINE CATHARTIC. /HEPTAHYDRATE, USP/

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 743

    FULL DOSES OF SALINE CATHARTICS (15 G MAGNESIUM SULFATE OR ITS EQUIVALENT) PRODUCE A SEMIFLUID OR WATERY EVACUATION IN 3 HR OR LESS. LOW DOSES PRODUCE A LAXATIVE EFFECT WITH GREATER LATENCY.

    Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 1005

    A COLD, WET COMPRESS OF MAGNESIUM SULFATE SOLN IN WATER HAS BEEN EMPLOYED IN TREATMENT OF SUCH SKIN DISORDERS AS ERYSIPELAS. HOT CONCN AQ SOLN...(ABOUT 1 LB/PINT OF WATER) ARE SOMETIMES USED IN TREATMENT OF DEEP-SEATED INFECTIONS, CLOTHS BEING SATURATED & APPLIED WHILE HOT. ACTION MUCH LIKE THAT OF POULTICE. /HEPTAHYDRATE/

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 743

    For more Therapeutic Uses (Complete) data for MAGNESIUM SULFATE (32 total), please visit the HSDB record page.

    4.3 Drug Warning

    SOME ABSORPTION OF COMPONENT IONS OF SALINE CATHARTICS DOES OCCUR, & IN CERTAIN INSTANCES THEY MAY PRODUCE SYSTEMIC TOXICITY. IN AN INDIVIDUAL WITH IMPAIRED RENAL FUNCTION, ACCUM OF MAGNESIUM IONS IN BODY FLUIDS MAY BE SUFFICIENT TO CAUSE INTOXICATION. MAGNESIUM CATHARTICS SHOULD BE ADMIN ONLY IF RENAL FUNCTION IS ADEQUATE.

    Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 1005

    THE DRUG IS GENERALLY SAFE BUT CAN CAUSE TEMPORARY LOSS OF DEEP TENDON REFLEXES IN MOTHER & MAY SUPPRESS SKELETAL MUSCLE ACTIVITY IN NEONATE. IT SHOULD NOT BE USED IN PT WITH HEART DISEASE...

    American Medical Association, AMA Department of Drugs. AMA Drug Evaluations. 4th ed. Chicago: American Medical Association, 1980., p. 798

    NEONATE MAY BE DROWSY & EXHIBIT RESP DIFFICULTIES & DIMINISHED MUSCLE TONE. HOWEVER...NO RELATIONSHIP BETWEEN PLASMA MAGNESIUM CONCN OF BLOOD COLLECTED FROM UMBILICAL CORD & THE APGAR SCORE /HAS BEEN FOUND/.

    Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 882

    Patients receiving parenteral magnesium sulfate shold be observed carefully, and serum magnesium concn should be monitored to avoid overdosage. ... An IV preparation of a calcium salt (e.g., calcium gluconate) should be readily available for use when magnesium sulfate is given IV. /Magnesium sulfate injection/

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 2163

    For more Drug Warnings (Complete) data for MAGNESIUM SULFATE (14 total), please visit the HSDB record page.

    4.4 Drug Indication

    Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Magnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.

    5.2 MeSH Pharmacological Classification

    Calcium Channel Blockers

    A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)

    Anti-Arrhythmia Agents

    Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

    Analgesics

    Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)

    Anticonvulsants

    Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)

    Tocolytic Agents

    Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)

    Anesthetics

    Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)

    5.3 FDA Pharmacological Classification
    5.3.1 Pharmacological Classes
    Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Calculi Dissolution Agent [EPC]
    5.4 ATC Code

    A - Alimentary tract and metabolism

    A06 - Drugs for constipation

    A06A - Drugs for constipation

    A06AD - Osmotically acting laxatives

    A06AD04 - Magnesium sulfate

    A - Alimentary tract and metabolism

    A12 - Mineral supplements

    A12C - Other mineral supplements

    A12CC - Magnesium

    A12CC02 - Magnesium sulfate

    B - Blood and blood forming organs

    B05 - Blood substitutes and perfusion solutions

    B05X - I.v. solution additives

    B05XA - Electrolyte solutions

    B05XA05 - Magnesium sulfate

    D - Dermatologicals

    D11 - Other dermatological preparations

    D11A - Other dermatological preparations

    D11AX - Other dermatologicals

    D11AX05 - Magnesium sulfate

    V - Various

    V04 - Diagnostic agents

    V04C - Other diagnostic agents

    V04CC - Tests for bile duct patency

    V04CC02 - Magnesium sulfate

    5.5 Absorption, Distribution and Excretion

    Route of Elimination

    Magnesium is excreted solely by the kidney at a rate proportional to the serum concentration and glomerular filtration.

    Magnesium sulfate is excreted by the kidneys at a rate that varies from one patient to another but that is directly proportional to the serum concn and glomerular filtration.

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 2164

    PLASMA CONCN OF MAGNESIUM INCR IN FETUS & APPROACH MATERNAL BLOOD VALUES AFTER MAGNESIUM SULFATE ADMIN IN ECLAMPSIA & PREECLAMPSIA.

    Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 882

    5.6 Metabolism/Metabolites

    None

    5.7 Biological Half-Life

    43.2 hours (for newborns)

    5.8 Mechanism of Action

    Magnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca2+ influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.

    CATHARTIC ACTION RESULTS FROM FACT THAT MGSO4 IS NOT ABSORBED FROM INTESTINAL TRACT, & THUS RETAINS SUFFICIENT WATER WITHIN LUMEN OF BOWEL TO MAKE AN ISOTONIC SOLN. IN EVENT...SALT IS GIVEN IN HYPERTONIC SOLN, SOURCE OF WATER WOULD BE BODY FLUIDS, &...DEHYDRATING ACTION IS EXERTED. /HEPTAHYDRATE, USP/

    Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 743

    EXACT MECHANISM OF.../CNS/ DEPRESSANT ACTIVITY IS NOT FULLY KNOWN; HOWEVER, EXCESS MAGNESIUM APPEARS TO DECR AMT OF ACETYLCHOLINE LIBERATED BY MOTOR NERVE IMPULSE. /HEPTAHYDRATE INJECTION USP/

    McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 2163

    Isolated myometrial strips were obtained from humans undergoing elective cesarean section at term pregnancy and Wistar albino rats on gestational days 19-21. These strips were mounted in organ baths for recording of isometric tensions. The effect of magnesium sulfate, isradipine, and ritodrine on the amplitude and frequency of spontaneous contractions was compared. ... Ritodrine (10-8-10-5 M) concentration-dependently inhibited the frequency and amplitude of spontaneous contractions of myometrial strips. At 10-4 M, tachyphylaxis of ritodrine occurred and contractions started again. Magnesium sulfate (10-7-10-4 M) inhibited the frequency but did not change the amplitude of the spontaneous contractions. Isradipine (10-7-10-4 M) had a concentration-related inhibitor effect on both the frequency and amplitude of the spontaneous contractions. The effects of magnesium sulfate, isradipine, and ritodrine were considerably similar in myometrium strips obtained from pregnant rats and humans. ...

    PMID:12225296 Kantas E, et al; Acta Obstet Gynecol Scand 81(9): 825-830 (2002)

    API SUPPLIERS

    read-more
    read-more

    01

    Jost Chemical

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Jost Chemical

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-07-15

    Pay. Date : 2014-07-02

    DMF Number : 25133

    Submission : 2011-07-05

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 55570-300

    Start Marketing Date : 2020-01-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Jost Chemical

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Jost Chemical

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 34100

    Submission : 2020-04-17

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 55570-300

    Start Marketing Date : 2020-01-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Tomita Pharmaceutical

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Tomita Pharmaceutical

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-05-21

    Pay. Date : 2013-09-27

    DMF Number : 26301

    Submission : 2012-08-08

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 227MF10134

    Registrant's Address : Tokushima Prefecture Naruto City Setocho Myojin Maruyama 85-1

    Initial Date of Registration : 2015-04-30

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Macco Organiques, Spol. s.r o

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Macco Organiques, Spol. s.r o

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2018-07-27

    Pay. Date : 2018-05-10

    DMF Number : 31105

    Submission : 2016-11-02

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Macco Organiques, Spol. s.r o

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Macco Organiques, Spol. s.r o

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 31874

    Submission : 2017-09-12

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Global Calcium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Global Calcium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2024-04-30

    Pay. Date : 2023-12-28

    DMF Number : 36873

    Submission : 2022-11-11

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Avantor Performance Materials

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Avantor Performance Materials

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 33571

    Submission : 2019-03-08

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 10106-5054

    Start Marketing Date : 2019-01-14

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    S D Fine Chem Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    S D Fine Chem Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 28690

    Submission : 2014-09-29

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Tomita Pharmaceutical

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Tomita Pharmaceutical

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25268

    Submission : 2011-04-27

    Status : Inactive

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 228MF10106

    Registrant's Address : Tokushima Prefecture Naruto City Setocho Myojin Maruyama 85-1

    Initial Date of Registration : 2016-06-06

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Tomita Pharmaceutical

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    Tomita Pharmaceutical

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 32931

    Submission : 2018-10-29

    Status : Inactive

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 227MF10096

    Registrant's Address : Tokushima Prefecture Naruto City Setocho Myojin Maruyama 85-1

    Initial Date of Registration : 2015-03-20

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Import","activeIngredients":"MAGNESIUM SULFATE HEPTAHYDRATE","year":"2021","qtr":"Q2","strtotime":1620930600,"product":"MAGNESIUM SULFATE HEPTAHYDRATE,USP (PARENTERAL DOSAGE FORM)","address":"6-3-865\/1\/2, FLAT NO.201,GREENLAND APARTMENTS, AMEERPET,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"TOMITA PHARMACEUTICAL","supplierCountry":"JAPAN","foreign_port":"OSAKA","customer":"GLAND PHARMA LIMITED","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"33","totalValueFC":"67352.1","currency":"USD","unitRateINR":"2466.8","date":"14-May-2021","totalValueINR":"4933500","totalValueInUsd":"67352.1","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3950022","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"OSAKA","supplierAddress":"","customerAddress":"6-3-865\/1\/2, FLAT NO.201,GREENLAND APARTMENTS, AMEERPET,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645295400,"product":"MAGNESIUM SULFATE","address":"SHANKAR TOWERS PLOT NO. A30,A.I.E BALANAGAR HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"M\/S. MACCO ORGANIQUES, S.R.O.","supplierCountry":"CZECH REPUBLIC","foreign_port":"NA","customer":"ANTHEA PHARMA PVT LTD","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"15.5","totalValueFC":"397.6","currency":"USD","unitRateINR":"1192","date":"20-Feb-2022","totalValueINR":"29800.91","totalValueInUsd":"397.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"7574319","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SHANKAR TOWERS PLOT NO. A30,A.I.E BALANAGAR HYDERABAD"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645295400,"product":"MAGNESIUM SULFATE, HEPTAHYDRATE PHEUR, USP, INJECTABLE GRADE","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"MACCO ORGANIQUES INC","supplierCountry":"CZECH REPUBLIC","foreign_port":"NA","customer":"HETERO DRUGS","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"16","totalValueFC":"811.7","currency":"USD","unitRateINR":"1216.8","date":"20-Feb-2022","totalValueINR":"60840","totalValueInUsd":"811.7","indian_port":"MADRAS AIR","hs_no":"29339990","bill_no":"7575043","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Sterile","supplierPort":"NA","supplierAddress":"","customerAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645986600,"product":"MAGNESIUM SULFATE","address":"Part of Plot No.11 & 87, Sy No.119 Phase - IV, Extension in IP, Pasham","city":"HYDERABAD","supplier":"TOMITA PHARMACEUTICAL","supplierCountry":"JAPAN","foreign_port":"NA","customer":"GLAND PHARMA LIMITED","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"34","totalValueFC":"68991.6","currency":"USD","unitRateINR":"2585.7","date":"28-Feb-2022","totalValueINR":"5171400","totalValueInUsd":"68991.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"7674941","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Part of Plot No.11 & 87, Sy No.119 Phase - IV, Extension in IP, Pasham"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719685800,"product":"3014181, 311378- RONACARE MAGNESIUM SULFATE 132219 (CODE. A319A) (RAW MATERIAL FOR MANUFACTURING OF COSMETIC) (NOT FOR F","address":"A-802, Crescenzo, C\/38-39, G-Block","city":"Mumbai","supplier":"INTERCOS EUROPE S.P.A","supplierCountry":"ITALY","foreign_port":"SEGRATE AIRPRT MILAN","customer":"INTERCOS INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"8.5","totalValueFC":"11.3","currency":"EUR","unitRateINR":"941.3","date":"30-Jun-2024","totalValueINR":"941.29","totalValueInUsd":"11.3","indian_port":"Delhi Air","hs_no":"29319090","bill_no":"4261989","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"SEGRATE AIRPRT MILAN","supplierAddress":"20123 MILANO, PIAZZA DIAZ, 1 Milano, , ItalySDNF Italy","customerAddress":"A-802, Crescenzo, C\/38-39, G-Block"}]
    14-May-2021
    30-Jun-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS ...DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 10GM/20ML (500MG/ML)

    USFDA APPLICATION NUMBER - 19316

    read-more

    DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS ...DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 1GM/2ML (500MG/ML)

    USFDA APPLICATION NUMBER - 19316

    read-more

    DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS ...DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 25GM/50ML (500MG/ML)

    USFDA APPLICATION NUMBER - 19316

    read-more

    DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS ...DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML)

    USFDA APPLICATION NUMBER - 19316

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)

    USFDA APPLICATION NUMBER - 200656

    read-more

    DOSAGE - POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;1...DOSAGE - POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT

    USFDA APPLICATION NUMBER - 204553

    read-more

    DOSAGE - TABLET;ORAL - 0.225GM;0.188GM;1.479G...DOSAGE - TABLET;ORAL - 0.225GM;0.188GM;1.479GM

    USFDA APPLICATION NUMBER - 213135

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Coating Systems & Additives

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Granulation

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Topical

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search